Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 5
1968 4
1969 7
1970 5
1971 4
1972 7
1973 4
1974 6
1975 15
1976 18
1977 14
1978 10
1979 9
1980 13
1981 7
1982 7
1983 5
1984 10
1985 13
1986 5
1987 8
1988 16
1989 8
1990 16
1991 6
1992 16
1993 18
1994 16
1995 12
1996 11
1997 14
1998 23
1999 16
2000 21
2001 17
2002 40
2003 19
2004 26
2005 28
2006 41
2007 47
2008 31
2009 31
2010 39
2011 44
2012 52
2013 39
2014 52
2015 31
2016 29
2017 17
2018 23
2019 12
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

935 results
Results by year
Filters applied: . Clear all
Page 1
Targeting JAK-STAT signal transduction in IBD
Soendergaard C, et al. Pharmacol Ther 2018 - Review. PMID 30048708
An unmet medical need exists for novel targeted therapies for inflammatory bowel disease (IBD) as many patients experience inadequate responses to antibody-based biologics. ...
An unmet medical need exists for novel targeted therapies for inflammatory bowel disease (IBD) as many patients experience ina …
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
Duboc H, et al. Gut 2013. PMID 22993202
As dysbiosis has been reported in inflammatory bowel diseases (IBD), we aim to investigate the impact of IBD-associated dysbiosis on BA metabolism and its influence on the epithelial cell inflammation response. ...In vitro, secondary BA exerted anti-inflammatory effects, but sulphation of secondary BAs abolished their anti-inflammatory properties. ...
As dysbiosis has been reported in inflammatory bowel diseases (IBD), we aim to investigate the impact of IBD-associated …
Investigating intestinal inflammation in DSS-induced model of IBD
Kim JJ, et al. J Vis Exp 2012. PMID 22331082 Free PMC article.
Inflammatory bowel disease (IBD) encompasses a range of intestinal pathologies, the most common of which are ulcerative colitis (UC) and Crohn's Disease (CD). ...Colonic histological damage is assessed by using a scoring system that considers loss of crypt architecture, inflammatory cell infiltration, muscle thickening, goblet cell depletion, and crypt abscess.(7) Quantitatively, levels of pro-inflammatory cytokines with acute inflammatory properties, such as interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α,can be determined using conventional ELISA methods. ...
Inflammatory bowel disease (IBD) encompasses a range of intestinal pathologies, the most common of which are ulcerative coliti
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
Buisson A, et al. J Clin Gastroenterol 2018 - Clinical Trial. PMID 28723856
BACKGROUND: Fecal biomarkers are emerging tools in the assessment of mucosal healing in inflammatory bowel diseases (IBD). GOALS: We aimed to evaluate the accuracy of fecal matrix metalloprotease-9 (MMP-9) and fecal lipocalin-2 (LCN-2) compared with calprotectin in detecting endoscopic activity in IBD STUDY:: Overall, 86 IBD adults underwent colonoscopy consecutively and prospectively, with Crohn's disease Endoscopic Index of Severity (CDEIS) in Crohn's disease (CD) patients or Mayo endoscopic subscore calculation for ulcerative colitis (UC) patients, and stool collection. ...
BACKGROUND: Fecal biomarkers are emerging tools in the assessment of mucosal healing in inflammatory bowel diseases (IB …
The PHD1 oxygen sensor in health and disease
Kennel KB, et al. J Physiol 2018 - Review. PMID 29435987 Free PMC article.
In this review, we focus on the physiology, pathophysiology and therapeutic potential of the PHD1 isoform, which has recently been implicated in diseases including inflammatory bowel disease, ischaemia and cancer....
In this review, we focus on the physiology, pathophysiology and therapeutic potential of the PHD1 isoform, which has recently been implicate …
[Dipeptidyl peptidase IV in inflammatory bowel diseases (DPP IV/CD26)].
Pučar LB, et al. Arh Hig Rada Toksikol 2012 - Review. PMID 22450208 Croatian.
Inflammatory bowel diseases (Crohn's disease, ulcerative colitis, undetermined colitis) are a group of chronic autoimmune inflammatory diseases distinguished by recurrent inflammation of various parts of the gastrointestinal (GI) system and presenting a significant public health problem. ...The aim of this review is to summarise earlier findings on different aspects of inflammatory bowel diseases, paying particular attention to the involvement of dipeptidyl peptidase IV (CD26 molecule, DPP IV/CD26) in the etiopathogenesis of inflammatory processes in the GI tract. ...
Inflammatory bowel diseases (Crohn's disease, ulcerative colitis, undetermined colitis) are a group of chronic autoimmu
Inhibition of histone deacetylases in inflammatory bowel diseases.
Glauben R and Siegmund B. Mol Med 2011 - Review. PMID 21365125 Free PMC article.
Furthermore, with regard to the relevance in human inflammatory bowel disease, the doses of ITF2357 considered safe in humans and the corresponding serum concentrations are consistent with the efficacious dosing used in our in vivo as well as in vitro experiments. Thus, the data strongly suggest that HDAC inhibitors could serve as a therapeutic option in inflammatory bowel disease....
Furthermore, with regard to the relevance in human inflammatory bowel disease, the doses of ITF2357 considered safe in humans …
[The role of intestinal alkaline phosphatase in pediatric inflammatory bowel and celiac diseases].
Molnár K, et al. Orv Hetil 2012 - Review. PMID 22935432 Hungarian.
The inappropriate immune responses and the damage of the mucosal barrier may contribute to the initiation of inflammatory bowel and celiac diseases. In the inflamed colonic mucosa of children with inflammatory bowel disease and in the duodenal mucosa of newly diagnosed children with celiac disease, the decreased intestinal alkaline phosphatase and increased Toll-like receptor 4 protein expression may generate enhanced lipopolysaccharide activity, which may strengthen tissue damaging processes. ...
The inappropriate immune responses and the damage of the mucosal barrier may contribute to the initiation of inflammatory bowel
Mast cells and inflammatory bowel disease.
Boeckxstaens G. Curr Opin Pharmacol 2015 - Review. PMID 26629596
Inflammatory bowel diseases (IBD), consisting of ulcerative colitis (UC) and Crohn's disease (CD), are chronic immune-mediated diseases of the gut. ...
Inflammatory bowel diseases (IBD), consisting of ulcerative colitis (UC) and Crohn's disease (CD), are chronic immune-m
935 results
Jump to page
Feedback